External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

CSCO 2024

-
Coming soon
02:00 PM
Duration 9hrs Xiamen, China
Entrectinib▼ in Asian patients with ROS1 fusion-positive (fp) non-small cell lung cancer (NSCLC): updated efficacy and safety analysis
Lu S, Fan, Y, Dong X, Yu Y, Li J, Zhao J, Lin C-C, Bradley D, Liu Y, Xu J, Hu X

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar